Acadia's schizophrenia treatment misses late-stage main goal; shares fall 16%

(Reuters) - Acadia Pharmaceuticals Inc said on Monday its add-on treatment for schizophrenia failed to meet the main goal in a late-stage study. The company's shares were down 16% at $21.62 in extended trading. In the study, 396 patients with moderate-to-severe psychotic symptoms were given Acadia's treatment pimavanserin or placebo as an add-on to their current antipsychotic treatment, the company said

Reuters July 23, 2019 04:06:22 IST
Acadia's schizophrenia treatment misses late-stage main goal; shares fall 16%

Acadias schizophrenia treatment misses latestage main goal shares fall 16

(Reuters) - Acadia Pharmaceuticals Inc said on Monday its add-on treatment for schizophrenia failed to meet the main goal in a late-stage study.

The company's shares were down 16% at $21.62 in extended trading.

In the study, 396 patients with moderate-to-severe psychotic symptoms were given Acadia's treatment pimavanserin or placebo as an add-on to their current antipsychotic treatment, the company said.

Adding pimavanserin to existing antipsychotic treatment showed a consistent trend in improvement of psychotic symptoms, however, the results did not show statistical significance in achieving the main goal, Acadia said.

A positive trend was observed in achieving the key secondary goal, Acadia said.

The U.S. Food and Drug Administration in 2016 approved pimavanserin for the treatment of hallucinations and delusions associated with Parkinson's disease.

Schizophrenia is a chronic, debilitating and often progressive mental illness characterized by disturbances in thinking, emotional reaction, and behaviour.

Acadia said about 1% of the U.S. population develops schizophrenia during their lifetime, citing the National Mental Health Institute data.

(Reporting by Aakash Jagadeesh Babu in Bengaluru; Editing by Anil D'Silva and Sriraj Kalluvila)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Water cannon fired at Frankfurt anti-lockdown rally
World

Water cannon fired at Frankfurt anti-lockdown rally

MUNICH/FRANKFURT (Reuters) - German police fired water cannon during an anti-lockdown rally in Frankfurt on Saturday and eventually broke up the gathering as rules like wearing masks and socially distancing were not observed. About 600 people from the loosely organized Querdenker movement that opposes the government’s measures to halt the rise in coronavirus infections took to the streets in Frankfurt.

Marie Antoinette's silk shoe goes up for sale in Versailles
World

Marie Antoinette's silk shoe goes up for sale in Versailles

By Christian Hartmann PARIS (Reuters) - A silk shoe that belonged to Marie Antoinette, the last queen of France who was executed during the French Revolution, will go up for auction on Sunday - with a starting price of 10,000 euros ($11,800).

Thai king calls for unity after protesters turn back on motorcade
World

Thai king calls for unity after protesters turn back on motorcade

By Juarawee Kittisilpa and Matthew Tostevin BANGKOK (Reuters) - Thailand's King Maha Vajiralongkorn told well-wishers of the importance of unity as he marked the opening of a new railway line on Saturday, after thousands of protesters had turned their backs on his motorcade as it passed through central Bangkok. Around 2,500 demonstrators had gathered at the capital's Democracy Monument in the latest of months of protests against Prime Minister Prayuth Chan-ocha, demanding changes to the constitution as well as reforms of the monarchy. The protesters draped the centrepiece of the monument, which has become a rallying point for the protests, in a cloth covered in grievances and insults